Faculty - CME colloquium

Faculty

International experts, all with different backgrounds, who will share their knowledge and personal view on the future of CME. Together with key stakeholders they will discuss how CME can evolve to produce better outcomes in a changing professional and societal environment.

.

Organising committee

Martin Michel

President ISSECAM, Pharmacology, Johannes Gutenberg-University, Mainz, Germany

Martin C. Michel is a physician and board-certified clinical pharmacologist currently working as Professor of Pharmacology at the Johannes Gutenberg University in Mainz (Germany). Previous key positions include Global Head of Product & Pipeline Support at Boehringer Ingelheim, Head of Dept. of Pharmacology & Pharmacotherapy at University of Amsterdam (Netherlands) and Head of Nephrology Research and Diagnostic labs at University of Essen (Germany). Key scientific interests are in the field of cardiovascular and urogenital pharmacology.

Mark Speakman

Secretary ISSECAM, Urology, Taunton and Somerset Hospital, Somerset, UK

Mark graduated in London (1978) and has been a consultant urologist in Taunton since 1990. He has undertaken research into benign and malignant prostate disease, bladder cancer and quality of life and published over 140 papers and 8 book chapters. He has supervised post-graduate students through MD, MS and PhD degrees and is current educational supervisor for the Foundation junior doctors. He was President of British Association of Urological Surgeons from 2014 – 2016.

Jaan Toelen

Treasurer ISSECAM, Paediatrics, UZ Leuven and Department of Development and Regeneration, KU Leuven, Belgium

Jaan Toelen is a Professor in the Paediatric Department of UZ Leuven (Belgium). He has a special interest in general paediatrics and diagnostics.
Prof. Toelen has established his research in the area of perinatal pulmonary disease. His research has resulted in a novel preterm rabbit model for studies into hyperoxia-induced lung injury. The model has been successfully employed to test the translational potential of 4 clinically relevant drugs.Professor Toelen dedicated his professional path to clinical practice, translational science and educational innovation.

Bertrand Tombal

Vice-president ISSECAM, Urology, University Hospital Saint-Luc, Brussels, Belgium

Prof Bertrand Tombal is Chairman of the Division of Urology and Professor of Urology at the Université catholique de Louvain (UCL), Cliniques universitaires Saint-Luc, Brussels, Belgium. He obtained his MD in 1990 and his PhD in 2003, both from UCL. His primary clinical interest is the treatment of advanced stages of prostate cancer, and particularly hormonal treatment and development of new biological agents. He is heading the uro-oncology division at UCL where he is coordinating several trials in this research area. Prof Tombal has authored many published papers, books, and book chapters.

Since September 2017, he is president of the European Organization for Research and Treatment in Cancer (EORTC), the leading European academic research organization in the field of cancer.

Faculty

Pieter Baeyaert

Google Marketing Solutions (BeLu),
Dublin, Ireland
Conflict of interest form

Biography
Pieter Baeyaert has been with Google for the past 6 years. During this time Pieter worked with SMBs in the Netherlands to advice on using ‘Digital’ to accelerate growth. Currently he is responsible for Sales in the Google Marketing Solutions department for Belgium and Luxembourg from the EMEA HQ in Dublin.

Ronald Cervero

Uniformed Services University of the Health Sciences, Bethesda (MD), USA
Conflict of interest form
Biography
Ronald M. Cervero, PhD, is Professor of Health Professions Education in the School of Medicine, Uniformed Services University of the Health Sciences. He earned his MA (social sciences) and PhD (Education) at the University of Chicago. Dr. Cervero has provided intellectual and organizational leadership for CME/health professions education over the course of his career and published extensively, with special emphasis on physicians’ continuing professional development.

Ruth Diazaraque

BioMarin EUMEA,
London, UK
Conflict of interest form

Biography

Ruth Diazaraque is the current Head of Medical Affairs for BioMarin in EUMEA. She has worked in Gilead Sciences, Pfizer and GSK in a number of roles and countries for the last 15 years, all of them in Medical Affairs. She is a certified specialist in Internal Medicine and holds a PhD with the Universidad Autónoma Madrid as well as a Master of Science in Statistics and Research Methods by the Universidad Autónoma Barcelona, a Master in Business Administration by IE Business School and a Master of Science in Pharmaceutical Medicine with Hibernia University, in Dublin. She also holds a honorary position in Chelsea and Westminster Hospital, looking after people living with HIV on a weekly basis. 

Ian Graham

Cardiovascular Medicine, Trinity College,
Dublin, Ireland
Conflict of interest form

Biography
Ian Graham is Professor of Cardiovascular Medicine in Trinity College Dublin with a special interest in risk estimation, audit, preventive cardiology, health policy and education. He is a Board member and Secretary-Treasurer of the European Society of Cardiology, and an author of the ESC Board paper “The future of continuing medical education: the roles of medical professional societies and the health care industry”.

Peter Littlejohns

Public Health, King’s College,
London, UK
Conflict of interest form

Biography

Peter is Professor of Public Health and Lead for Education in the School of Population Health and Environmental Sciences at Kings College London. He is an Honorary Medical Consultant to Guy’s and St Thomas’ NHS Foundation Trust and Deputy Director of the National Institute for Health Research Collaboration for Leadership in Health Research and Care, South London. From 1919-2012 he was the founding Clinical and Public Health Director of the National Institute for Health and Care Excellence (NICE). Since leaving NICE in 2012 he has established an international research programme to undertake a cross-national exploration of the different ways in which values are constructed and incorporated into decisions about healthcare resource allocation in different countries.

Martin Michel

Pharmacology, Johannes Gutenber-University, Mainz, Germany
Conflict of interest form
Biography
Martin C. Michel is a physician and board-certified clinical pharmacologist currently working as Professor of Pharmacology at the Johannes Gutenberg University in Mainz (Germany). Previous key positions include Global Head of Product & Pipeline Support at Boehringer Ingelheim, Head of Dept. of Pharmacology & Pharmacotherapy at University of Amsterdam (Netherlands) and Head of Nephrology Research and Diagnostic labs at University of Essen (Germany). Key scientific interests are in the field of cardiovascular and urogenital pharmacology.

Nele Michels

Centre for General Practice, Faculty of Medicine and Health Sciences, University, Antwerp, Belgium
Conflict of interest form

Biography

Prof. Nele Michels M.D, Ph.D. is GP at a group practice in Antwerp, Belgium, and assistant professor at the Faculty of Medicine and Health Sciences, University of Antwerp. She is educational coordinator and vice-director of the Educational Committee General Practice at the Centre for General Practice, Antwerp and co-coordinator of the Skills Lab at the Faculty of Medicine. For the Flemish Interuniversity Centre for the Education of General Practitioners she is director of the Steering Group Workplace Learning and a member of the Steering Group Curriculum & Assessment. Board Member of the Educational Council at the Faculty of Medicine and Health Sciences and Board Member of the Educational Council at the University of Antwerp. She is an active member of the Scientific Committee of the Dutch-Flemish Society of Medical Education and EURACT representative council member, chair of the Specialty Training Committee.

Vassilios Papalois

Professor of Surgery, Imperial College, Secretary General-UEMS, London, UK
Conflict of interest form

Biography

Vassilios Papalois is Professor of Transplantation Surgery and Consultant Transplant and General Surgeon at the Hammersmith Hospital, Imperial College, London, UK.  He leads a Transplant Centre of Excellence focusing on high risk and extended criteria kidney and pancreas transplantation. 

He is the Secretary General of the European Union of Medical Specialists (UEMS) and organises annually a series of advanced international courses on transplant training, clinical ethics and health policy and has given more than 150 lectures in international forums as an invited speaker. 

 

Jana Lizrova Preiningerova

Neurology, Charles University, Prague,
Czech Republic
Conflict of interest form

Biography
Dr. Jana Lizrova Preiningerova is a clinician scientist in the field of multiple sclerosis and clinical faculty at the Charles University, School of Medicine, in Prague.
She graduated from the First School of Medicine at Charles University in Prague in 1994, where she also completed her board certification in neurology. Her career continued at Yale University, where she focused on translational research, clinical research, clinical care of patients with multiple sclerosis, and pre-postgraduate teaching until 2009. She then relocated with her family back to Prague, where she joined a large academic MS clinic. She divides her time into clinical care, research and education. She enjoys her teaching responsibilities at the pregraduate and postgraduate levels, as well as creating different formats of knowledge exchange at the peer level.

Birgitte Schoenmakers

Public Health and Primary Care, University, Leuven, Belgium
Conflict of interest form
Biography
Prof Dr. Schoenmakers is a general practitioner and currently Head of Academic Teaching Practice Leuven. She is the designer of the assessment program of the advanced master in Family Medicine and of the recently installed proficiency test for Family Medicine candidates. She also developed a digital platform to assess and evaluate students. In the university teaching practice, trainees and residents are observed using video tracking during real life patient encounters. Birgitte Schoenmakers is also the co-creator of a digital e-learning platform in close collaboration with ACCO Publishers.

Mark Speakman

Urology, Taunton and Somerset Hospital, Somerset, UK
Conflict of interest form
Biography
Mark graduated in London (1978) and has been a consultant urologist in Taunton since 1990. He has undertaken research into benign and malignant prostate disease, bladder cancer and quality of life and published over 140 papers and 8 book chapters. He has supervised post-graduate students through MD, MS and PhD degrees and is current educational supervisor for the Foundation junior doctors. He was President of British Association of Urological Surgeons from 2014 – 2016.

Eva Thalmann

Janssen Pharmaceutical Companies of Johnson & Johnson, Vienna, Austria
Conflict of interest form

Biography

Eva Hofstädter-Thalmann is Strategic Lead in Medical Education and External Scientific Relations Lead for Oncology at Janssen Medical Affairs Europe, Middle East and Africa. Throughout her carrier she was working in Hematology/Oncology, Immunology, Nephrology and Virology. As External Scientific Relations Lead Oncology, Eva is focusing on strong strategic collaborations to major Oncology societies as well as top experts and publishers. Beside this her focus is on strategic quality aspects for Janssen in education over all disease areas.
Eva is member of several external strategic groups such as ESMO Committee Member for Women4Oncology, Chair of the EFPIA Medical Education Working Group, board member of JECME and Chair of the international Pharmaceutical Alliance of CME (iPACME).
Eva Thalmann obtained a PhD in Biochemistry from the University of Vienna and joined Janssen-Cilag in 1990. She had various positions in Medical Affairs and Strategic Marketing for Janssen-Cilag and Johnson & Johnson within Europe and US.

Jaan Toelen

Paediatrics, UZ Leuven and Department of Development and Regeneration, KU Leuven, Belgium
Conflict of interest form
Biography
Jaan Toelen is a Professor in the Paediatric Department of UZ Leuven (Belgium). He has a special interest in general paediatrics and diagnostics. Prof. Toelen has established his research in the area of perinatal pulmonary disease. His research has resulted in a novel preterm rabbit model for studies into hyperoxia-induced lung injury. The model has been successfully employed to test the translational potential of 4 clinically relevant drugs. Professor Toelen dedicated his professional path to clinical practice, translational science and educational innovation.

Bertrand Tombal

Urology, University Hospital Saint-Luc,
Brussels, Belgium
Conflict of interest form

Biography
Prof Bertrand Tombal is Chairman of the Division of Urology and Professor of Urology at the Université catholique de Louvain (UCL), Cliniques universitaires Saint-Luc, Brussels, Belgium. He obtained his MD in 1990 and his PhD in 2003, both from UCL. His primary clinical interest is the treatment of advanced stages of prostate cancer, and particularly hormonal treatment and development of new biological agents. He is heading the uro-oncology division at UCL where he is coordinating several trials in this research area. Prof Tombal has authored many published papers, books, and book chapters.

Since September 2017, he is president of the European Organization for Research and Treatment in Cancer (EORTC), the leading European academic research organization in the field of cancer.